Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Income from Continuing Operations (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) posted Income from Continuing Operations of $2.16 billion for Q3 2026, down 1.5% from $2.2 billion a year earlier and down 34.8% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Income from Continuing Operations (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Income from Continuing Operations at Bristol Myers Squibb was $9.24 billion, up 52.9% year-over-year; for FY2025, it was $7.06 billion.

  • In prior years, Bristol Myers Squibb's Income from Continuing Operations was -$8.93 billion in FY2024, $8.04 billion in FY2023 (+26.7%), $6.35 billion in FY2022 (-9.5%) and $7.01 billion in FY2021.
  • Quarterly Income from Continuing Operations has run from a low of -$11.91 billion in Q1 2024 to a high of $3.32 billion in Q2 2026 over five years.
  • On a year-over-year basis, Income from Continuing Operations increased in three of the last six quarters, with growth averaging 20.5%.
  • The strongest year-over-year quarter for Income from Continuing Operations in the past five years was Q2 2026, with growth of 152.6%; the weakest was Q4 2024, with a decline of 95.7%.
  • According to Business Quant data, Income from Continuing Operations for the three prior quarters was $3.32 billion (Q2 2026), $2.68 billion (Q1 2026) and $1.09 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 210.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.22 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.80 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.25 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 2.16 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.16 Bn
Jun 30, 2026 3.32 Bn
Mar 31, 2026 2.68 Bn
Dec 31, 2025 1.09 Bn
Sep 30, 2025 2.20 Bn
Jun 30, 2025 1.31 Bn
Mar 31, 2025 2.46 Bn
Dec 31, 2024 76.00 Mn
Sep 30, 2024 1.22 Bn
Jun 30, 2024 1.68 Bn
Mar 31, 2024 -11.91 Bn
Dec 31, 2023 1.76 Bn
Sep 30, 2023 1.93 Bn
Jun 30, 2023 2.08 Bn
Mar 31, 2023 2.27 Bn
Dec 31, 2022 2.03 Bn
Sep 30, 2022 1.61 Bn
Jun 30, 2022 1.43 Bn
Mar 31, 2022 1.28 Bn
Dec 31, 2021 2.37 Bn
API Access

Bristol Myers Squibb Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=BMY&period=max&api_key=YOUR_API_KEY